Cargando…
Mild Paravalvular Leak May Pose an Increased Thrombogenic Risk in Transcatheter Aortic Valve Replacement (TAVR) Patients-Insights from Patient Specific In Vitro and In Silico Studies
In recent years, the treatment of aortic stenosis with TAVR has rapidly expanded to younger and lower-risk patients. However, persistent thrombotic events such as stroke and valve thrombosis expose recipients to severe clinical complications that hamper TAVR’s rapid advance. We presented a novel met...
Autores principales: | Kovarovic, Brandon J., Rotman, Oren M., Parikh, Puja B., Slepian, Marvin J., Bluestein, Danny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952825/ https://www.ncbi.nlm.nih.gov/pubmed/36829682 http://dx.doi.org/10.3390/bioengineering10020188 |
Ejemplares similares
-
Device Thrombogenicity Emulation: An In Silico Predictor of In Vitro and In Vivo Ventricular Assist Device Thrombogenicity
por: Chiu, Wei Che, et al.
Publicado: (2019) -
The native aortic valve reduces paravalvular leak in TAVR patients
por: Prisco, Anthony R., et al.
Publicado: (2022) -
Aortic Paravalvular Leak Repair: Can TAVR Be the Answer?
por: Abdel-Aal Ahmed, Mohamed, et al.
Publicado: (2019) -
Plugging Paravalvular Leak in Transcatheter Aortic Valves
por: Conte, Sean M., et al.
Publicado: (2019) -
CMR to stratify post-TAVR paravalvular leak in patients with suboptimal echocardiography
por: Hartlage, Gregory, et al.
Publicado: (2014)